Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 3
1981 2
1982 5
1983 3
1984 3
1985 4
1986 5
1987 2
1988 3
1989 3
1992 1
1993 1
1994 2
1995 1
1998 1
1999 1
2000 2
2004 2
2006 1
2007 4
2008 4
2009 3
2010 3
2011 6
2012 4
2013 6
2014 6
2015 9
2016 5
2017 3
2018 3
2019 4
2020 6
2021 5
2022 10
2023 14
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Molecular portraits of human breast tumours.
Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Botstein D. Perou CM, et al. Among authors: zhu sx. Nature. 2000 Aug 17;406(6797):747-52. doi: 10.1038/35021093. Nature. 2000. PMID: 10963602
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.
Strand SH, Rivero-Gutiérrez B, Houlahan KE, Seoane JA, King LM, Risom T, Simpson LA, Vennam S, Khan A, Cisneros L, Hardman T, Harmon B, Couch F, Gallagher K, Kilgore M, Wei S, DeMichele A, King T, McAuliffe PF, Nangia J, Lee J, Tseng J, Storniolo AM, Thompson AM, Gupta GP, Burns R, Veis DJ, DeSchryver K, Zhu C, Matusiak M, Wang J, Zhu SX, Tappenden J, Ding DY, Zhang D, Luo J, Jiang S, Varma S, Anderson L, Straub C, Srivastava S, Curtis C, Tibshirani R, Angelo RM, Hall A, Owzar K, Polyak K, Maley C, Marks JR, Colditz GA, Hwang ES, West RB. Strand SH, et al. Among authors: zhu sx. Cancer Cell. 2022 Dec 12;40(12):1521-1536.e7. doi: 10.1016/j.ccell.2022.10.021. Epub 2022 Nov 17. Cancer Cell. 2022. PMID: 36400020 Free PMC article.
Cost-effective DNA methylation profiling by FML-seq.
Foley JW, Zhu SX, West RB. Foley JW, et al. Among authors: zhu sx. Life Sci Alliance. 2023 Sep 29;6(12):e202302326. doi: 10.26508/lsa.202302326. Print 2023 Dec. Life Sci Alliance. 2023. PMID: 37775270 Free PMC article.
Cost-effective DNA methylation profiling by FML-seq.
Foley JW, Zhu SX, West RB. Foley JW, et al. Among authors: zhu sx. bioRxiv [Preprint]. 2023 Jul 17:2023.01.13.523849. doi: 10.1101/2023.01.13.523849. bioRxiv. 2023. PMID: 36711549 Free PMC article. Updated. Preprint.
MicroRNAs in gastric cancer: from bench to bedside.
Hu ML, Xiong SW, Zhu SX, Xue XX, Zhou XD. Hu ML, et al. Among authors: zhu sx. Neoplasma. 2019 Mar 5;66(2):176-186. doi: 10.4149/neo_2018_180703N439. Epub 2018 Sep 29. Neoplasma. 2019. PMID: 30509106 Review.
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.
Strand SH, Rivero-Gutiérrez B, Houlahan KE, Seoane JA, King LM, Risom T, Simpson LA, Vennam S, Khan A, Cisneros L, Hardman T, Harmon B, Couch F, Gallagher K, Kilgore M, We S, DeMichele A, King T, McAuliffe PF, Nangia J, Lee J, Tseng J, Storniolo AM, Thompson AM, Gupta GP, Burns R, Veis DJ, DeSchryver K, Zhu C, Matusiak M, Wang J, Zhu SX, Tappenden J, Ding DY, Zhang D, Luo J, Jiang S, Varma S, Anderson L, Straub C, Srivastava S, Curtis C, Tibshirani R, Angelo RM, Hall A, Owzar K, Polyak K, Maley C, Marks JR, Colditz GA, Hwang ES, West RB. Strand SH, et al. Among authors: zhu sx. Cancer Cell. 2023 Jul 10;41(7):1381. doi: 10.1016/j.ccell.2023.06.002. Cancer Cell. 2023. PMID: 37433282 Free PMC article. No abstract available.
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study.
Yan XQ, Ye MJ, Zou Q, Chen P, He ZS, Wu B, He DL, He CH, Xue XY, Ji ZG, Chen H, Zhang S, Liu YP, Zhang XD, Fu C, Xu DF, Qiu MX, Lv JJ, Huang J, Ren XB, Cheng Y, Qin WJ, Zhang X, Zhou FJ, Ma LL, Guo JM, Ding DG, Wei SZ, He Y, Guo HQ, Shi BK, Liu L, Liu F, Hu ZQ, Jin XM, Yang L, Zhu SX, Liu JH, Huang YH, Xu T, Liu B, Sun T, Wang ZJ, Jiang HW, Yu DX, Zhou AP, Jiang J, Luan GD, Jin CL, Xu J, Hu JX, Huang YR, Guo J, Zhai W, Sheng XN. Yan XQ, et al. Among authors: zhu sx. Ann Oncol. 2024 Feb;35(2):190-199. doi: 10.1016/j.annonc.2023.09.3108. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37872020 Free article. Clinical Trial.
138 results